Nov 27, 2018 - The ecosystem backed by cloud-based informatics research platform is likely to drive Accenture's (ACN) Products Segment.
Nov 29, 2018 - The large-cap pharma industry has been on a strong footing lately. Here are four stocks from the space that investors may consider betting on.
Nov 29, 2018 - Despite stock market mayhem, fundamentals of the U.S. economy remain strong which will help sustain the rally.
Nov 29, 2018 - Moderna aims to raise $500 million in the largest development stage biotech IPO.The firm has developed an mRNA-based platform to advance an ambitious pipeline of vaccines and therapeutics for a range
Nov 30, 2018 - Novartis (NVS) gains the EU approval for MS drug Gilenya for children who are 10-17 years old with relapsing-remitting forms of multiple sclerosis.
Dec 03, 2018 - Shire's (SHPG) gets European approval for Takhzyro subcutaneous injection, for routine prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older.
Dec 04, 2018 - Incyte (INCY) announces positive data on lead drug Jakafi at the ASH meet for the indication of acute GVHD.
Dec 05, 2018 -
Dec 06, 2018 - IDMC recommends AbbVie (ABBV) to stop enrolment in a late-stage study on its small cell lung cancer candidate, Rova-T.
Dec 07, 2018 - Novartis (NVS) presents supplementary data from phase III study on BYL719 in combination with Faslodex for the treatment of advanced breast cancer. The study scripts success in PFS.